K894002

Substantially Equivalent

CYTOMEGALOVIRUS FLUORESCENT MONOCLONAL ANTIBODY

Applicant: Baxter Healthcare Corp
Product code: LIN
Advisory panel: Microbiology
Date received: 1989-06-05
Decision date: 1989-08-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.